Yi Huang

Shandong Center for Disease Control and Prevention

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “820P Phase II study of pamiparib in Chinese patients (pts) with advanced ovarian cancer (aOC)”.

820P Phase II study of pamiparib in Chinese patients (pts) with advanced ovarian cancer (aOC)

Annals of Oncology(2020)10.1016/j.annonc.2020.08.959

N/A

0DataRank · unranked

2 citations

Jianqing Zhu, Jun Wang, Zhongqiu Lin, Beihua Kong, Raymond Yin +15 more

Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: a cross-sectional study

medRxiv(2021)10.1101/2021.04.22.21255769

N/A

0DataRank · unranked

19 citations

R. Taylor Sundby, Paul A. Jones, Divya Srihari, Noah Earland, Peter K. Harris +16 more